Search

everythinglearnresearchcommunity

for

Search:↓

PP405 shows promise in treating severe hair loss, with 31% of users experiencing over 20% hair density increase in four weeks, faster than minoxidil and finasteride. Some users are skeptical about the results' significance and long-term efficacy.

The conversation is about hair loss treatments, specifically using dermarolling, rosemary oil, and minoxidil. The user experienced side effects with finasteride and is considering alternative treatments.

RU58841 helped regrow hairline without side effects for a bodybuilder using PEDs. The treatment included RU58841, finasteride, minoxidil, GKH-Cu, microneedling, and HGH.

A 19-year-old male experiencing diffuse hair thinning has been using oral minoxidil and finasteride for 6 months with no improvement. Suggestions include continuing the treatment, checking for underlying conditions, and considering nutritional or hormonal causes.

The user is experiencing sudden hair loss and is considering micro-needling, low-level light therapy, iron supplements, folihair, and Omega 3. They are hesitant to start finasteride, suspecting the hair loss might be due to telogen effluvium from a past COVID-19 infection.

The conversation is about starting a hair loss treatment with oral and topical Minoxidil, 1mg Finasteride, and a Biotin supplement. The user is advised to start with the prescribed 1mg Finasteride and lower the dose if side effects occur.

The conversation discusses diffuse unpatterned alopecia (DUPA) and its possible causes, including sensitivity to DHT, not being androgenic alopecia, being diffuse alopecia areata, or hormonal issues. Treatments mentioned include topical melatonin, Clobetasol Propionate for alopecia areata, and the lack of results from using finasteride, dutasteride, and minoxidil.

The user noticed hair regrowth after supplementing with vitamin D, magnesium, zinc, and vitamin B12, alongside using minoxidil for 3 years. They observed a lower hairline and improved density, supported by photographic evidence.

The use of tropoelastin injections and verteporfin for hair transplant recipients to help regrow donor area hairs, as well as research done on tropoelastin injections restoring elastin in scarred heart tissue and skin. There are discussions about why it is taking so long to get cosmetic mass produced tropoelastin injectables on the market.

A user switched from topical to oral finasteride (0.5mg daily) and continued using topical minoxidil, seeing significant improvement in hair loss over four months. The user is pleased with the results, especially on the crown, and notes that hairline recession has stopped.

Finasteride can help extend the hair growth cycle and improve hair density, allowing for long hair despite initial shedding. Periodic shedding may occur, but it typically does not affect healthy hair significantly.

A 42-year-old male has reached a plateau in hair regrowth after 8 months using Dutasteride, Minoxidil, a dermaroller, and Ketoconazole. Suggestions include continuing treatment, considering a hair transplant, and improving nutrition.

A 21-year-old is experiencing aggressive hair loss despite using minoxidil, dutasteride, and GFC, and is seeking advice on whether to switch treatments or consider a hair transplant. Suggestions include continuing current treatments, checking for underlying health issues, and considering alternatives like RU58841 or microneedling.

A 42-year-old male experienced hair regrowth using a topical treatment of finasteride, ketoconazole, and minoxidil, noticing increased hair density and reduced hair loss over a year. He plans to switch to oral finasteride and continue using topical minoxidil, with a dermatologist's guidance.

PP405 shows promise in hair regrowth, with 31% of participants experiencing over 20% increase in hair density after 8 weeks. Phase 3 trials are expected in 2026, with potential market availability by 2029-2031.

A 21-year-old from Germany is experiencing a receding hairline and is considering treatments like Finasteride and Minoxidil. They are unsure whether to consult a general practitioner or dermatologist and are concerned about being taken seriously due to their age.

SCUBE3 is available online but poses risks like tumor promotion and high costs. Users advise against using it due to health concerns and inefficacy as a standalone treatment.

A 28-year-old woman with genetic hair loss has tried various treatments, including oral minoxidil, finasteride, dutasteride, vitamins, ketoconazole shampoo, exosome needling, and hair extensions. She plans to pause treatments for pregnancy and is concerned about potential hair loss during that time.

Person 1, with slow hair loss, might need less finasteride than Person 2, who is balding rapidly. The suggested doses are 0.25 mg finasteride three times a week for Person 1 and 1 mg daily for Person 2.

A user nearing 9 months of hair loss treatment reports using Minoxidil 5% liquid twice daily, Finasteride 1mg daily, and microneedling with a 1.5mm roller weekly. They also take Vitamin D, B7, Zinc, and considered but did not use Dutasteride or Ketoconazole shampoo.

The user has been on finasteride for over four years without noticeable results and recently added dutasteride and RU58841, but continues to experience hair loss. They are considering stopping all medications due to lack of effectiveness and side effects like extremely dry eyes from dutasteride.

A user shared progress pictures showing hair growth after 5.5 and 8 weeks of using Minoxidil twice daily, oral Finasteride once daily, Vitamin C once daily, derma stamping twice weekly, and Nizoral shampoo three times per week. Some replies express skepticism, while others share their own experiences and advise moderation in treatment.

The user experienced persistent acne and skin issues with dutasteride, leading them to stop its use. They switched to finasteride, which caused mild acne and potential liver concerns, prompting consideration of alternative treatments like topical finasteride and GHK-Cu.

A user shared positive results from using 0.5 mg finasteride daily for 3.5 months, noting no side effects and visible hair regrowth. Others commented on their experiences, with some expressing hope and others cautioning about potential side effects.

Extended-release oral minoxidil (VDPHL01) shows promising results for hair growth with improved safety, achieving significant hair count increases and minimal side effects compared to placebo. The treatment is designed to maintain effective concentrations while reducing side effects, making it a safer option for those who cannot tolerate standard minoxidil.

The conversation is about a person experiencing treatment-resistant androgenic alopecia despite using high doses of dutasteride and minoxidil, along with other treatments like microneedling and purilutamide. Suggestions include considering a hair transplant, checking medication authenticity, and exploring other treatments like RU58841 or topical estradiol.

Hair loss treatments discussed include microneedling, minoxidil, tretinoin, finasteride, dutasteride, pumpkin seeds, saw palmetto, and scalp massage. The consensus is that finasteride or dutasteride is necessary for significant regrowth, while other methods may only slow hair loss.

A 25-year-old male experienced hair loss and tried various treatments, including finasteride, PRP, mesotherapy, dutasteride, and oral minoxidil. Despite some setbacks and treatment interruptions, recent photos show improved hair density, though the user remains uncertain about overall progress.

COVID and COVID vaccination can trigger hair loss, primarily telogen effluvium, due to stress and immune system activation. Proper diagnosis and addressing factors like nutrition and stress are crucial for recovery.

The user is experiencing significant hair shedding and suspects it may be due to low serum ferritin levels rather than worsening androgenetic alopecia. They have resumed iron supplementation and are seeking additional solutions to address the shedding.